Note 10 - Revenue and Geographic Information

9 Months Ended

Sep. 30, 2024

Notes to Financial Statements

Revenue from Contract with Customer [Text Block]

10. Revenue and Geographic Information

Revenue by product family is as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2024		2023		2024		2023
OA Pain Management	$	24,428	$	24,888	$	75,404	$	76,855
Joint Preservation and Restoration		11,950		13,470		39,345		39,583
Non-Orthopedic		2,375		3,107		6,448		7,253
	$	38,753	$	41,465	$	121,197	$	123,691

Revenue from the Company’s sole significant US customer, J&J Medtech (previously known as DePuy Synthes Mitek Sports Medicine), part of the Johnson & Johnson Medical Companies, as a percentage of the Company’s total revenue was 45% and 44% for the three-months ended September 30, 2024 and 2023, respectively, and 43% and 45% for the nine-months ended September 30, 2024 and 2023, respectively.

Total revenue by geographic location based on the location of the customer in total and as a percentage of total revenue were as follows:

	Three Months Ended September 30,
	2024					2023
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	27,699		71	%	$	30,831		74	%
Europe		5,688		15	%		5,420		13	%
Other		5,366		14	%		5,214		13	%
Total	$	38,753		100	%	$	41,465		100	%

	Nine Months Ended September 30,
	2024					2023
			Percentage of					Percentage of
	Revenue		Revenue			Revenue		Revenue
Geographic Location:
United States	$	85,923		71	%	$	90,986		74	%
Europe		18,264		15	%		16,757		13	%
Other		17,010		14	%		15,948		13	%
Total	$	121,197		100	%	$	123,691		100	%